Cover ImageSALE
市場調查報告書

心臟心律調節器的全球市場:2017年∼2021年

Global Cardiac Pacemakers Market 2017-2021

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 297458
出版日期 內容資訊 英文 83 Pages
訂單完成後即時交付
價格
Back to Top
心臟心律調節器的全球市場:2017年∼2021年 Global Cardiac Pacemakers Market 2017-2021
出版日期: 2017年08月22日 內容資訊: 英文 83 Pages
簡介

全球心臟心律調節器市場,隨著心血管疾病的增加,預計從2017年到2021年,以12.90%的年複合成長率擴大。還有該市場,無導線心律調節器的開發有所發展。

本報告以南北美洲,歐洲、中東、非洲地區,亞太地區的心臟心律調節器市場作為調查範圍,提供全球市場的現狀與其預測,各產品的市場趨勢,市場發展因素與課題,主要供應商分析等,為您概述為以下內容。

第1章 摘要整理

第2章 調查範圍

第3章 市場調查手法

第4章 簡介

  • 市場概要

第5章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 各產品的市場區隔

  • 全球植入式心臟心律調節器市場
  • 全球體外式心臟心律調節器市場

第7章 各技術的市場區隔

  • 市場概要
  • 單腔心臟心律調節器
  • 二腔心臟心律調節器
  • 二心室心律調節器

第8章 各終端用戶的市場區隔

  • 醫院
  • 外科門診診療所(ASC)
  • 診療所

第9章 地理區分

  • 概要
  • 南北美洲
  • 歐洲、中東、非洲地區
  • 亞太地區

第10章 決策結構

第11章 市場成長因素與課題

第12章 市場趨勢

第13章 業者情勢

  • 競爭模式
  • 其他卓越供應商

第14章 主要供應商分析

  • Abbott
  • BIOTRONIK
  • Boston Scientific
  • Medtronic

第15章 附錄

  • 簡稱清單

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR14571

About Cardiac Pacemakers

A pacemaker is a small device that sends electrical impulses to the heart muscle to maintain a suitable heart rate and rhythm. Pacemaker generates an electrical impulse that passes through the leads (wires) to the heart muscles. This causes the heart muscles to contract, thus creating a heartbeat. A pacemaker may also be used to treat fainting spells (syncope), congestive heart failure, and, rarely, hypertrophic cardiomyopathy. These devices are used for regulating the heartbeat of individuals and are segmented into products such as implantable cardiac pacemakers and external cardiac pacemakers.

Technavio's analysts forecast the global cardiac pacemakers market to grow at a CAGR of 12.90% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global cardiac pacemakers market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of cardiac pacemakers.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Cardiac Pacemakers Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott
  • BIOTRONIK
  • Boston Scientific
  • Medtronic

Other Prominent Vendors

  • Cardiac Science (a subsidiary of Quinton Cardiology)
  • CCC Medical Devices
  • Cook Medical
  • GE Healthcare (a subsidiary of General Electric Company
  • MEDICO
  • SORIN GROUP (a subsidiary of LivaNova)
  • ZOLL Medical Corporation (a subsidiary of Asahi Kasei Corporation)

Market driver

  • Decline in the prices of pacemakers
  • For a full, detailed list, view our report

Market challenge

  • High competition from substitutes
  • For a full, detailed list, view our report

Market trend

  • Focus on new product launches*
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Market outline

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by product

  • Implantable cardiac pacemakers
  • External cardiac pacemakers

PART 07: Market segmentation by technology

  • Market overview
  • Single-chamber cardiac pacemakers
  • Dual-chamber cardiac pacemakers
  • Bi-ventricular cardiac pacemakers

PART 08: Market segmentation by end-users

  • Hospitals
  • ASCs
  • Clinics

PART 09: Geographical segmentation

  • Overview
  • Cardiac pacemakers market in Americas
  • Cardiac pacemakers market in EMEA
  • Cardiac pacemakers market in APAC

PART 10: Decision framework

PART 11: Drivers and challenges

  • Market drivers
  • Market challenges

PART 12: Market trends

  • Focus on new product launches*
  • Supportive government and non-government initiatives

PART 13: Vendor landscape

  • Vendor landscape
  • Other prominent vendors

PART 14: Key vendor analysis

  • Abbott
  • BIOTRONIK
  • Boston Scientific
  • Medtronic

PART 15: Appendix

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Global cardiac pacemakers market 2016-2021 ($ billions)
  • Exhibit 02: Five forces analysis
  • Exhibit 03: Segmentation of global cardiac pacemakers market by product 2016
  • Exhibit 04: Global implantable cardiac pacemakers market 2016-2021 ($ billions)
  • Exhibit 05: Global external cardiac pacemakers market 2016-2021 ($ billions)
  • Exhibit 06: Segmentation of global cardiac pacemakers market by technology 2016 (%)
  • Exhibit 07: Segmentation of global cardiac pacemakers market by technology 2021 (%)
  • Exhibit 08: Global single-chamber cardiac pacemakers market 2016-2021 ($ billions)
  • Exhibit 09: Global dual-chamber cardiac pacemakers market 2016-2021 ($ billions)
  • Exhibit 10: Global bi-ventricular cardiac pacemakers market 2016-2021 ($ billions)
  • Exhibit 11: Global cardiac pacemakers market by geography 2016 (%)
  • Exhibit 12: Global cardiac pacemakers market by geography 2021 (%)
  • Exhibit 13: Cardiac pacemaker market overview in US
  • Exhibit 14: Heart disease cases in US 2011-2014
  • Exhibit 15: Cardiac pacemakers market in Americas 2016-2021 ($ billions)
  • Exhibit 16: Cardiac pacemakers market overview in Germany
  • Exhibit 17: Cardiac pacemaker market in EMEA 2016-2021 ($ billions)
  • Exhibit 18: Cardiac pacemakers market overview in Japan
  • Exhibit 19: Cardiac pacemaker market in APAC 2016-2021 ($ billions)
  • Exhibit 20: Complications associated with implantable pacemakers
  • Exhibit 21: Abbott: Key highlights
  • Exhibit 22: Abbott: Strength assessment
  • Exhibit 23: Abbott: Strategy assessment
  • Exhibit 24: Abbott: Opportunity assessment
  • Exhibit 25: BIOTRONIK: Key highlights
  • Exhibit 26: BIOTRONIK: Strength assessment
  • Exhibit 27: BIOTRONIK: Strategy assessment
  • Exhibit 28: BIOTRONIK: Opportunity assessment
  • Exhibit 29: Boston Scientific: Key highlights
  • Exhibit 30: Boston Scientific: Strength assessment
  • Exhibit 31: Boston Scientific: Strategy assessment
  • Exhibit 32: Boston Scientific: Opportunity assessment
  • Exhibit 33: Medtronic: Key highlights
  • Exhibit 34: Medtronic: Strength assessment
  • Exhibit 35: Medtronic: Strategy assessment
  • Exhibit 36: Medtronic: Opportunity assessment
Back to Top